Mei-Ling Kuo
- Oncology top 5%
- Cancer-related Molecular Pathways 8
- Peptidase Inhibition and Analysis 3
- Molecular Biology top 10%
- RNA modifications and cancer 6
- Ubiquitin and proteasome pathways 6
- Epigenetics and DNA Methylation 3
- DNA Repair Mechanisms 1
-
- Cancer, Hypoxia, and Metabolism 1
- Hematology top 10%
- Biotechnology top 10%
-
- Statistical and numerical algorithms 1
- Co-authors
- Charles J. SherrMartine F. RousselWillem den BestenMasataka SugimotoJason D. WeberDavid BertwistleEnrico L. DiGiammarinoRichard W. Kriwacki
- Partner nations
- United StatesTaiwanAustralia
In The Last Decade
Mei-Ling Kuo
17 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 77
- Oncology 596
- Molecular Biology 998
- Cancer Research 155
- Hematology 100
- Biotechnology 62
Countries citing papers authored by Mei-Ling Kuo
This map shows the geographic impact of Mei-Ling Kuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Ling Kuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Ling Kuo more than expected).
Fields of papers citing papers by Mei-Ling Kuo
This network shows the impact of papers produced by Mei-Ling Kuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Ling Kuo. The network helps show where Mei-Ling Kuo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mei-Ling Kuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 13 | |
| 2 | 2014 | 2 | |
| 3 | 2012 | 32 | |
| 4 | 2011 | 52 | |
| 5 | 2011 | 43 | |
| 6 | 2009 | 6 | |
| 7 | 2008 | 18 | |
| 8 | 2008 | 58 | |
| 9 | 2006 | 9 | |
| 10 | 2005 | 85 | |
| 11 | 2004 | 34 | |
| 12 | 2004 | 15 | |
| 13 | 2004 | 172 | |
| 14 | 2003 | 233 | |
| 15 | Arf induces p53-dependent and -independent antiproliferative genes. | 2003 | 87 |
| 16 | The RING domain of Mdm2 can inhibit cell proliferation. | 2002 | 74 |
| 17 | 2000 | 237 |
About Mei-Ling Kuo
Mei-Ling Kuo is a scholar working on Oncology, Molecular Biology, Statistics and Probability, Analytical Chemistry and Finance, having authored 17 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (8 papers), RNA modifications and cancer (6 papers), Ubiquitin and proteasome pathways (6 papers), Epigenetics and DNA Methylation (3 papers), Peptidase Inhibition and Analysis (3 papers), Statistical and numerical algorithms (1 paper), DNA Repair Mechanisms (1 paper) and Cancer, Hypoxia, and Metabolism (1 paper). The work is most often cited by research in Oncology (596 citations), Molecular Biology (998 citations), Cancer Research (155 citations), Hematology (100 citations) and Biotechnology (62 citations). Mei-Ling Kuo has collaborated with scholars based in United States, Taiwan and Australia. Frequent co-authors include Charles J. Sherr, Martine F. Roussel, Willem den Besten, Masataka Sugimoto, Jason D. Weber, David Bertwistle, Enrico L. DiGiammarino, Richard W. Kriwacki, Brian Bothner and Richard T. Williams. Their work appears in journals such as Cell Cycle, Molecular Cancer Therapeutics, Scientific Reports, Statistical Applications in Genetics and Molecular Biology and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.